SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 2 filers reported holding SUMMIT THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS (UK) LLP | 2,667,350 | $7,922,000 | 0.33% |
| Polar Capital LLP | 4,500,000 | $13,365,000 | 0.12% |
| Inscription Capital, LLC | 17,000 | $50,000 | 0.03% |
| BBR PARTNERS, LLC | 50,000 | $149,000 | 0.02% |
| Checchi Capital Advisers, LLC | 20,000 | $59,000 | 0.01% |
| Cornerstone Investment Partners, LLC | 34,825 | $103,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 49,257 | $146,000 | 0.00% |
| Renaissance Technologies | 361,112 | $1,073,000 | 0.00% |
| HSBC HOLDINGS PLC | 150,975 | $448,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 11,000 | $35,000 | 0.00% |